Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod IncfiledCriticalPfizer Prod Inc
Priority to CR6934ApriorityCriticalpatent/CR6934A/en
Publication of CR6934ApublicationCriticalpatent/CR6934A/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Se refiere a nuevos derivados de piperazina, a procedimientos de uso y a composiciones farmaceuticas que los contiene. Los compuestos son potentes y selectivos inhibdores de las quimiocinas que se unen al receptor CCR1 encontrado en las celulas inflamatorias e inmunomoduladoras (preferiblemente leucocitos y linfocitos)It refers to new piperazine derivatives, methods of use and pharmaceutical compositions containing them. The compounds are potent and selective inhibitors of chemokines that bind to the CCR1 receptor found in inflammatory and immunomodulatory cells (preferably leukocytes and lymphocytes)
CR6934A2003-03-252003-03-25
BRIDGE DERIVATIVES OF PIPERAZINA.
CR6934A
(en)